Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.59B | 4.19B | 4.02B | 4.17B | 4.63B |
Gross Profit | 2.65B | 2.54B | 2.46B | 2.55B | 2.82B |
EBITDA | 255.83M | 194.09M | 94.62M | 16.36M | 129.66M |
Net Income | 52.58M | -69.88M | -110.23M | -215.26M | -103.87M |
Balance Sheet | |||||
Total Assets | 2.85B | 2.98B | 2.93B | 3.11B | 3.13B |
Cash, Cash Equivalents and Short-Term Investments | 514.86M | 597.50M | 510.14M | 555.62M | 360.16M |
Total Debt | 2.19B | 2.40B | 2.46B | 2.47B | 2.52B |
Total Liabilities | 2.71B | 2.90B | 2.93B | 3.06B | 3.11B |
Stockholders Equity | 139.36M | 83.73M | 2.56M | 44.62M | 18.80M |
Cash Flow | |||||
Free Cash Flow | 64.06M | 83.39M | -104.58M | -100.30M | 147.82M |
Operating Cash Flow | 221.59M | 172.16M | -83.26M | -32.44M | 231.27M |
Investing Cash Flow | -99.49M | 187.56M | -23.66M | 37.95M | -58.55M |
Financing Cash Flow | -204.75M | -276.55M | 61.44M | 189.96M | -97.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $1.54T | 10.56 | 12.49% | 3.71% | 12.68% | 94.75% | |
79 Outperform | ¥3.21T | 9.62 | 12.68% | 2.95% | 4.46% | 12.53% | |
77 Outperform | $1.56T | 12.53 | 13.61% | 2.44% | 22.05% | 215.17% | |
76 Outperform | $1.12T | 15.50 | 8.70% | 2.08% | 1.02% | 5782.30% | |
69 Neutral | ¥105.84B | 16.12 | 3.76% | 2.61% | -9.19% | ||
67 Neutral | ¥263.01B | 13.51 | 6.45% | 2.58% | 5.16% | -13.18% | |
60 Neutral | ¥1.25B | 13.14 | 0.55% | 6.53% | ― |